... Bioorganic & Medicinal Chemistry Letters. ... 6 and 14 In this letter, we report on our efforts to design a novel series of NS3/4A protease inhibitors obtained by further truncation of the N-terminal part of previously reported macrocyclic series (eg, BILN 2061, 1). 11. ...